Enzymotec Granted Patent for Its Composition of Vayacog® Addressing Memory and Mild Cognitive Impairment
Published: Oct 30, 2013
MIGDAL HA'EMEQ, ISRAEL, Oct. 30, 2013 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-functional lipid ingredients, announced today that it was granted a patent by the U.S. Patent and Trademark Office for its composition of Vayacog® and its use in age-associated memory impairment and mild cognitive impairment.
Help employers find you! Check out all the jobs and post your resume.